TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21266647

Group type: EXPERIMENTAL
Intervention: Mean sensor glucose concentration (area under the curve)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Mean sensor glucose concentrations
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Root mean square of the errors
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Median absolute difference
Number of subjects: 252
Study: 19182079

Group type: EXPERIMENTAL
Intervention: Bobath Concept
Number of subjects: 813

Group type: COMPARATOR
Intervention: Other approaches
Number of subjects: 813
Study: 16885220

Group type: EXPERIMENTAL
Intervention: Intervention to restore normal blood flow
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 87
Study: 15283001

Group type: EXPERIMENTAL
Intervention: L-dopa (200 mg) plus carbidopa (50 mg) administered at night (11 pm)
Number of subjects: 24

Group type: COMPARATOR
Intervention: L-dopa (200 mg) plus carbidopa (50 mg) administered during the day (11 am)
Number of subjects: 24
Study: 11738102

Group type: EXPERIMENTAL
Intervention: Lamivudine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 8989345

Group type: EXPERIMENTAL
Intervention: 750 mg/kg RSV‐IGIV
Number of subjects: 510

Group type: COMPARATOR
Intervention: Placebo (1% albumin)
Number of subjects: 510
Study: 8235924

Group type: EXPERIMENTAL
Intervention: Cefotaxime 500 mg intramuscularly
Number of subjects: 613

Group type: COMPARATOR
Intervention: Ceftriaxone 250 mg intramuscularly
Number of subjects: 613
Study: 3321412

Group type: EXPERIMENTAL
Intervention: Norfloxacin 200 mg or 400 mg b.i.d. for 7 days
Number of subjects: 651

Group type: EXPERIMENTAL
Intervention: Norfloxacin 400 mg b.i.d.
Number of subjects: 651

Group type: COMPARATOR
Intervention: Trimethoprim/sulfamethoxazole
Number of subjects: 651

Group type: EXPERIMENTAL
Intervention: Ampicillin, cephalothin, sulfamethoxazole
Number of subjects: 651

Group type: EXPERIMENTAL
Intervention: Nalidixic acid, mecillinam
Number of subjects: 651

Group type: EXPERIMENTAL
Intervention: Cefotaxime, gentamicin, trimethoprim
Number of subjects: 651
Study: 31122227

Group type: EXPERIMENTAL
Intervention: Pilates Group (n=37)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Aerobic Group (n=37)
Number of subjects: 74
Study: 29912453

Group type: EXPERIMENTAL
Intervention: rMVA-H5
Number of subjects: 79

Group type: COMPARATOR
Intervention: Vector control
Number of subjects: 79
Study: 26783237

Group type: EXPERIMENTAL
Intervention: Early fibrinolysis
Number of subjects: 1859

Group type: EXPERIMENTAL
Intervention: Primary percutaneous coronary intervention
Number of subjects: 1859

Group type: COMPARATOR
Intervention: Both reperfusion strategies
Number of subjects: 1859
Study: 23632272

Group type: EXPERIMENTAL
Intervention: Question Prompt Sheet (QPS)
Number of subjects: 100
Study: 22101497

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (IVB) at baseline, month 1, and month 2
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combined IVB and macular grid laser photocoagulation
Number of subjects: 18
Study: 19640941

Group type: EXPERIMENTAL
Intervention: Interactive booklet on respiratory tract infections
Number of subjects: 528

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 528
Study: 17311647

Group type: EXPERIMENTAL
Intervention: Octreotide 50 mu 12 h subcutaneously for a 1-2 yr period
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (1 tablet/day)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 16235871

Group type: EXPERIMENTAL
Intervention: Modified Matrix (MM) model of supervision
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Centre for Health and Social Studies (CHESS) model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (District C)
Number of subjects: 0
Study: 11918228

Group type: EXPERIMENTAL
Intervention: 5 ml of cod liver oil with vitamin D (n = 575)
Number of subjects: 1144

Group type: COMPARATOR
Intervention: 5 ml of cod liver oil without vitamin D (n = 569)
Number of subjects: 1144
Study: 9439181

Group type: EXPERIMENTAL
Intervention: American Cancer Society (ACS) guidelines
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: US Preventive Services Task Force (USPSTF) guidelines
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Compilation of various guidelines
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: No guidelines
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Cancer screening practices
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Coronary artery disease screening practices
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Treatment of depression
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Obesity/diabetes mellitus treatment
Number of subjects: 300
Study: 8129410

Group type: EXPERIMENTAL
Intervention: Topical tretinoin (0.025% cream)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Low-dose oral isotretinoin (10 mg/d)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Combined use of isotretinoin and tretinoin
Number of subjects: 22

Group type: COMPARATOR
Intervention: Tretinoin cream
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 22
Study: 2679513

Group type: EXPERIMENTAL
Intervention: PGE2 vaginal gel (1 or 2mg, repeated if necessary at 6 hours)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Oxytocin (via amniotomy)
Number of subjects: 320
Study: 1097747

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 0
Study: 30716123

Group type: EXPERIMENTAL
Intervention: Copenhagen Triage Algorithm (CTA)
Number of subjects: 45347

Group type: COMPARATOR
Intervention: Adaptive Process Triage (ADAPT)
Number of subjects: 45347
Study: 27863326

Group type: EXPERIMENTAL
Intervention: Active video game intervention (AVG), 30-35 minutes/day for 16 weeks
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Active video game intervention (AVG)
Number of subjects: 21
Study: 25700289

Group type: EXPERIMENTAL
Intervention: Baseline 24‐hour Holter ECG monitoring with AF auto‐detect external loop recorder for 30 days.
Number of subjects: 237

Group type: COMPARATOR
Intervention: APB count categories based on Holter ECG monitoring.
Number of subjects: 237
Study: 22672611

Group type: EXPERIMENTAL
Intervention: Synthetic bone graft Straumann Bone Ceramic (SBC) with collagen barrier
Number of subjects: 27

Group type: COMPARATOR
Intervention: Deproteinized bovine bone mineral (DBBM) with collagen barrier
Number of subjects: 27
Study: 21123762

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of atrial natriuretic peptide (ANP) at 10 ng·kg(‐1)·min(‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of angiotensin II (ANG II) at 10 ng·kg(‐1)·min(‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ANG II with simultaneous infusion of nitroprusside
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simultaneous intravenous infusion of ANP (10 ng·kg(‐1)·min(‐1)) with ANG II and nitroprusside
Number of subjects: 0
Study: 19204058

Group type: EXPERIMENTAL
Intervention: Postnatal corticosteroids (dexamethasone), total dose tertiles: <0.9, 0.9‐1.9, and >/=1.9 mg/kg
Number of subjects: 2358

Group type: EXPERIMENTAL
Intervention: Postnatal corticosteroids (dexamethasone) after 33 weeks' postmenstrual age
Number of subjects: 2358

Group type: EXPERIMENTAL
Intervention: Postnatal corticosteroids (dexamethasone) in neonates at high risk for bronchopulmonary dysplasia
Number of subjects: 2358
Study: 17292022

Group type: EXPERIMENTAL
Intervention: Acupuncture (RCT)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Acupuncture (OS)
Number of subjects: 145
Study: 15365275

Group type: COMPARATOR
Intervention: Lisinopril up-titration (40 mg for 8 weeks)
Number of subjects: 1096

Group type: EXPERIMENTAL
Intervention: Lisinopril plus candesartan (16 mg for 2 weeks followed by 32 mg for 6 weeks)
Number of subjects: 1096

Group type: EXPERIMENTAL
Intervention: Post hoc pooled analysis of lisinopril plus candesartan
Number of subjects: 1096
Study: 16232173

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (n=43)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (n=43)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (n=29)
Number of subjects: 120
Study: 10321674

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (5 mg/kg/hr for 6 hrs on 6 successive days)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 8846875

Group type: EXPERIMENTAL
Intervention: Normal loop colostomy
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Functional terminal colostomy (TA 55 stapler)
Number of subjects: 16
Study: 2018406

Group type: EXPERIMENTAL
Intervention: Recall periods ranging from 'the past 3 days' to 'the past year' and 'usual intake' (Study 1 and 2)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Short recall periods (e.g., last weekend, the past 5 days) (Study 3)
Number of subjects: 232
Study: 7057164

Group type: EXPERIMENTAL
Intervention: Self-instruction group (n = 10)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Attention-placebo control (n = 9)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 29
Study: 31590139

Group type: EXPERIMENTAL
Intervention: ALERTA ALCOHOL intervention
Number of subjects: 1247

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1247
Study: 29590436

Group type: EXPERIMENTAL
Intervention: Alcohol Care Management (ACM)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 163
Study: 26679977

Group type: EXPERIMENTAL
Intervention: Nasally inhaled isopropyl alcohol
Number of subjects: 84

Group type: COMPARATOR
Intervention: Nasally inhaled normal saline solution (placebo)
Number of subjects: 84
Study: 24845609

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (400 mg, 3 times daily)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Prednisolone (40 mg daily)
Number of subjects: 121
Study: 22194371

Group type: EXPERIMENTAL
Intervention: Posterior vertebral arch cement augmentation (spinoplasty)
Number of subjects: 35

Group type: COMPARATOR
Intervention: No spinoplasty (control group)
Number of subjects: 35
Study: 20640997

Group type: EXPERIMENTAL
Intervention: Harmonic scalpel (HS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional techniques (CT)
Number of subjects: 30
Study: 19063731

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin therapy (10 ml/kg over 4-6 hours, repeated 48 hours later)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15652873

Group type: EXPERIMENTAL
Intervention: Risperidone treatment
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Haloperidol treatment
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 44
Study: 11818199

Group type: EXPERIMENTAL
Intervention: Oral UFT 300 mg/m2/day plus oral LV 90 mg/day for 28 days every 5 weeks
Number of subjects: 37

Group type: COMPARATOR
Intervention: i.v. 5‐FU 425 mg/m2/day plus LV 20 mg/m2/day for 5 days every 4 weeks
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Oral UFT
Number of subjects: 37

Group type: COMPARATOR
Intervention: i.v. 5‐FU
Number of subjects: 37
Study: 10743481

Group type: EXPERIMENTAL
Intervention: Sunflower oil
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Glucose with first meal
Number of subjects: 11

Group type: COMPARATOR
Intervention: Rapeseed oil, Sunflower oil, Palm oil
Number of subjects: 11
Study: 8820252

Group type: EXPERIMENTAL
Intervention: Isradipine (5 mg capsules)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 18
Study: 30907143

Group type: EXPERIMENTAL
Intervention: Functional Independence Measure (FIM)
Number of subjects: 3506

Group type: COMPARATOR
Intervention: EQ-5D-3L
Number of subjects: 3506
Study: 31423755

Group type: EXPERIMENTAL
Intervention: Knee flexion strength training at short muscle length
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Knee flexion strength training at optimal muscle length
Number of subjects: 12
Study: 28645291

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (5 mg intravenous infusion)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 25510286

Group type: EXPERIMENTAL
Intervention: Oral fish oil supplementation
Number of subjects: 562

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: NT‐proBNP
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: hs‐cTnT
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: NT‐proBNP and hs‐cTnT levels
Number of subjects: 562
Study: 23623849

Group type: EXPERIMENTAL
Intervention: NS1209
Number of subjects: 28

Group type: COMPARATOR
Intervention: Phenytoin/Valproate (third-line standard treatment)
Number of subjects: 28
Study: 21823043

Group type: EXPERIMENTAL
Intervention: Pioglitazone (15-30 mg/day)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Metformin (500-750 mg/day)
Number of subjects: 68
Study: 19318433

Group type: EXPERIMENTAL
Intervention: MMS19L genotype (chromosome 10q24.1)
Number of subjects: 1143

Group type: EXPERIMENTAL
Intervention: Haplotype analysis of MMS19L
Number of subjects: 1143

Group type: EXPERIMENTAL
Intervention: Seven individual SNPs in MMS19L
Number of subjects: 1143
Study: 16413335

Group type: EXPERIMENTAL
Intervention: Bipolar plasmakinetic TURP (Gyrus device)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard monopolar TURP
Number of subjects: 70
Study: 15720808

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with 5-FU
Number of subjects: 166

Group type: COMPARATOR
Intervention: No adjuvant chemotherapy
Number of subjects: 166
Study: 11401110

Group type: EXPERIMENTAL
Intervention: Subcutaneous erythropoietin (EPO) and intravenous (IV) iron
Number of subjects: 32

Group type: COMPARATOR
Intervention: Not treated (Control Group B)
Number of subjects: 32
Study: 9424006

Group type: EXPERIMENTAL
Intervention: Hyperfractionated XRT (total dose 69.60‐76.80 Gy, 1.2 Gy b.i.d. five times a week) combined with superficial external HT (2 to 6 sessions)
Number of subjects: 27
Study: 8499097

Group type: EXPERIMENTAL
Intervention: 200 micrograms/d of misoprostol, increased every 5 days by 200 micrograms until a total of 800 micrograms/d was achieved
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 3800150

Group type: EXPERIMENTAL
Intervention: Atropine methonitrate (AM) 125 micrograms 3 times a day for 5 days
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Atropine methonitrate (AM) 250 micrograms 4 times a day for 5 days
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 34
Study: 31723017

Group type: EXPERIMENTAL
Intervention: In-depth prompt about care breakdowns
Number of subjects: 1188

Group type: EXPERIMENTAL
Intervention: Full apology
Number of subjects: 1188

Group type: COMPARATOR
Intervention: No prompt
Number of subjects: 1188

Group type: COMPARATOR
Intervention: No apology
Number of subjects: 1188
Study: 31519279

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Stress Reduction (MBSR)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 127
Study: 28173775

Group type: EXPERIMENTAL
Intervention: HiBalance program (highly challenging balance training) provided by physical therapists as part of standard rehabilitation care.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HiBalance program (highly challenging balance training)
Number of subjects: 0
Study: 24921211

Group type: EXPERIMENTAL
Intervention: Rabeprazole, Amoxicillin, and Clarithromycin (RAC)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Rabeprazole, Amoxicillin, and Metronidazole (RAM)
Number of subjects: 124
Study: 23627960

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 22091740

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICSs)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Oral corticosteroids
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Short-acting β‐agonist
Number of subjects: 125
Study: 19071883

Group type: EXPERIMENTAL
Intervention: Mipomersen sodium 200 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Simvastatin 40 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ezetimibe 10 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Mipomersen sodium
Number of subjects: 10
Study: 16874795

Group type: EXPERIMENTAL
Intervention: Knee OA pain assessment using visual analog scale; Knee OA function assessment using Western Ontario and McMaster Universities Osteoarthritis Index function subscale.
Number of subjects: 1290

Group type: EXPERIMENTAL
Intervention: Acute RCS pain assessment using numeral rating scale; RCS function assessment using Neer function subscale.
Number of subjects: 1290

Group type: EXPERIMENTAL
Intervention: Functional impairment assessment for knee OA.
Number of subjects: 1290
Study: 12893645

Group type: EXPERIMENTAL
Intervention: Low dose house dust mite allergen exposure
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: RV16 infection
Number of subjects: 36
Study: 10883566

Group type: EXPERIMENTAL
Intervention: High-risk intervention group
Number of subjects: 153

Group type: COMPARATOR
Intervention: High-risk control group
Number of subjects: 153

Group type: COMPARATOR
Intervention: Functional comparison group
Number of subjects: 153
Study: 9012701

Group type: EXPERIMENTAL
Intervention: Serum oncostatin M (OSM) levels in OSM+ patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Serum IL‐6 levels
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Serum C‐reactive protein (CRP) levels
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Serum beta 2M concentration
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Serum sIL‐6R levels
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Clinical data (age, gender, myeloma protein or stage)
Number of subjects: 40
Study: 8268899

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg daily
Number of subjects: 4396

Group type: EXPERIMENTAL
Intervention: Combined tablet containing hydrochlorothiazide 25 mg and amiloride 2.5 mg
Number of subjects: 4396

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4396
Study: 2880460

Group type: EXPERIMENTAL
Intervention: Procyclidine, Orphenadrine, Trihexyphenidyl hydrochloride (1/3 DDD)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 29400921

Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg once daily for up to 28 days
Number of subjects: 540

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study: 28251654

Group type: EXPERIMENTAL
Intervention: BGCC (3 g d-1) for 12 weeks
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 25677127

Group type: EXPERIMENTAL
Intervention: Self-regulation intervention
Number of subjects: 315

Group type: COMPARATOR
Intervention: Information provision (control)
Number of subjects: 315
Study: 22863840

Group type: EXPERIMENTAL
Intervention: Aprepitant
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study: 21492347

Group type: EXPERIMENTAL
Intervention: Blended Learning (BL)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Face-to-Face Learning (F2FL)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: E-learning (EL)
Number of subjects: 90
Study: 19738017

Group type: EXPERIMENTAL
Intervention: n-propanol 89.5% for 2 min application
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Ethanol and isopropanol
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Alcohol supplemented with 0.5% or more chlorhexidine digluconate (CHG)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: n-propanol 89.5%
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Combination of n-propanol with CHG
Number of subjects: 180

Group type: COMPARATOR
Intervention: 0.5%, 1%, or 2% chlorhexidine digluconate (CHG) in 89.5% n-propanol
Number of subjects: 180
Study: 16368077

Group type: EXPERIMENTAL
Intervention: Dexamethasone/corticotropin-releasing hormone (DEX/CRH) test after 8 weeks of antidepressant treatment
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Higher posttreatment maximal cortisol response on the DEX/CRH test
Number of subjects: 45
Study: 15270974

Group type: EXPERIMENTAL
Intervention: Frova single-use introducer
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Eschmann multiple-use introducer
Number of subjects: 48

Group type: COMPARATOR
Intervention: Portex single-use introducer
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Frova and Portex introducers
Number of subjects: 48
Study: 12143474

Group type: EXPERIMENTAL
Intervention: Healthy Start program (intervention group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No participation in the Healthy Start program (control group)
Number of subjects: 0
Study: 9489938

Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Diazepam (5 mg and 10 mg)
Number of subjects: 12
Study: 7996118

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine (KT) 60 mg to 2 ml
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (sodium chloride, 0.9%)
Number of subjects: 40
Study: 2725404

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 103
Study: 5411599

Group type: EXPERIMENTAL
Intervention: Silicone oil
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Hydrocortisone acetate
Number of subjects: 71

Group type: COMPARATOR
Intervention: Hydrocortisone acetate plus saline
Number of subjects: 71
Study: 31778291

Group type: EXPERIMENTAL
Intervention: Stratified exercise therapy (subgroup-specific protocolized exercise therapy, with dietary intervention for obesity subgroup)
Number of subjects: 408

Group type: COMPARATOR
Intervention: Usual care by physical therapists (nonstratified exercise therapy)
Number of subjects: 408
Study: 28502744

Group type: EXPERIMENTAL
Intervention: High-dose sodium selenite (4000 μg IV after induction, 1000 μg/d during ICU stay)
Number of subjects: 411

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 411